Alison J. McManus

564 total citations
10 papers, 96 citations indexed

About

Alison J. McManus is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Alison J. McManus has authored 10 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Neurology and 2 papers in Neurology. Recurrent topics in Alison J. McManus's work include Prion Diseases and Protein Misfolding (3 papers), Neurological diseases and metabolism (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Alison J. McManus is often cited by papers focused on Prion Diseases and Protein Misfolding (3 papers), Neurological diseases and metabolism (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Alison J. McManus collaborates with scholars based in United States, United Kingdom and Australia. Alison J. McManus's co-authors include Steven E. Arnold, Bianca A. Trombetta, Jessica Gerber, Kaj Blennow, Mark H. Wilcox, Matthew Dryden, Sonia M. Vallabh, Chloe K. Nobuhara, Eric Vallabh Minikel and Thomas L Holland and has published in prestigious journals such as Neurology, Antimicrobial Agents and Chemotherapy and BMC Medicine.

In The Last Decade

Alison J. McManus

9 papers receiving 95 citations

Peers

Countries citing papers authored by Alison J. McManus

Since Specialization

Citations

This map shows the geographic impact of Alison J. McManus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison J. McManus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison J. McManus more than expected).

Fields of papers citing papers by Alison J. McManus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison J. McManus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison J. McManus. The network helps show where Alison J. McManus may publish in the future.

Co-authorship network of co-authors of Alison J. McManus

This figure shows the co-authorship network connecting the top 25 collaborators of Alison J. McManus. A scholar is included among the top collaborators of Alison J. McManus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison J. McManus. Alison J. McManus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment 2025 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·Chao‐Yi Wu, (unknown), Chen Liu, Alison J. McManus, Pia Kivisäkk, (unknown), Nadine A. Schwab, (unknown), Victoria J. Williams, Jessica Gerber, Misha M. Riley, (unknown), Edmarie Guzmán‐Vélez, Hiroko H. Dodge, Rudolph E. Tanzi, Clifford M. Singer, Steven E. Arnold	4
2	Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial 2025 ·EClinicalMedicine ·Chao‐Yi Wu, William Reynolds, (unknown), Alison J. McManus, Charles Brenner, (unknown), (unknown), (unknown), Jonathan Rosand, Rudolph E. Tanzi, Steven E. Arnold, Edmarie Guzmán‐Vélez	0
3	Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease 2024 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·Steven E. Arnold, Suzanne Hendrix, Jessie Nicodemus‐Johnson, (unknown), Victoria J. Williams, Jeffrey M. Burns, (unknown), Alison J. McManus, Sanjeev Vaishnavi, Zoe Arvanitakis, Judith Neugroschl, Karen L. Bell, Bianca A. Trombetta, Becky C. Carlyle, Pia Kivisäkk, Hiroko H. Dodge, Rudolph E. Tanzi, Patrick Yeramian, Kent Leslie	5
4	Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion 2024 ·Neurology ·Sonia M. Vallabh, (unknown), Shona W. Allen, (unknown), Pia Kivisäkk, (unknown), (unknown), Bianca A. Trombetta, (unknown), (unknown), (unknown), (unknown), (unknown), Jessica Gerber, Alison J. McManus, Eric Vallabh Minikel, Steven E. Arnold	3
5	Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS 2022 ·JCI Insight ·(unknown), Hien Zhao, Andrew G. Reidenbach, (unknown), Eric Kuhn, Jill O’Moore, Patrick M. Dooley, (unknown), Curt Mazur, Shona W. Allen, Bianca A. Trombetta, Alison J. McManus, (unknown), (unknown), Deborah E. Cabin, Holly Kordasiewicz, Joel Mathews, Steven E. Arnold, Sonia M. Vallabh, Eric Vallabh Minikel	10
6	Using Proteomics Analysis to Identify Cerebrospinal Fluid Biomarkers in Normal Pressure Hydrocephalus 2022 ·Alzheimer s & Dementia ·(unknown), (unknown), Bianca A. Trombetta, (unknown), (unknown), Misha M. Riley, Alison J. McManus, Anne‐Marie Wills, Pia Kivisäkk, Becky C. Carlyle, Steven E. Arnold	1
7	A pilot protocol to assess the feasibility of a virtual multiple crossover, randomized controlled trial design using methylphenidate in mild cognitive impairment 2020 ·Trials ·(unknown), Victoria J. Williams, Alison J. McManus, Anoopum S. Gupta, Becky C. Carlyle, Hamed Azami, Jessica Gerber, (unknown), (unknown), Rebecca A. Betensky, Steven E. Arnold	1
8	Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease 2020 ·BMC Medicine ·Sonia M. Vallabh, Eric Vallabh Minikel, Victoria J. Williams, Becky C. Carlyle, Alison J. McManus, (unknown), (unknown), Bianca A. Trombetta, (unknown), Chloe K. Nobuhara, Jessica Gerber, (unknown), Ingolf Lachmann, Christiane Stehmann, Steven Collins, Kaj Blennow, Henrik Zetterberg, Steven E. Arnold	29
9	Clinical Trials and Tribulations in the COVID-19 Era 2020 ·American Journal of Geriatric Psychiatry ·Marc S. Weinberg, Regan Patrick, Nadine A. Schwab, (unknown), (unknown), Alison J. McManus, Jessica Gerber, David G. Harper, Steven E. Arnold, Brent P. Forester	12
10	A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study) 2018 ·Antimicrobial Agents and Chemotherapy ·Thomas L Holland, William O’Riordan, Alison J. McManus, (unknown), (unknown), Thomas M. File, Mark H. Wilcox, Antoni Torres, Matthew Dryden, Thomas P. Lodise, Toyoko Oguri, G. Ralph Corey, Patrick McLeroth, (unknown), David B. Huang	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact